Mainly engaged in the theory and clinical research of collateral diseases in traditional Chinese medicine, pioneered the application of collateral diseases theory to guide the scientific research and clinical treatment of cardiovascular and cerebrovascular diseases, diabetes, neuromuscular diseases and other diseases, and developed national new drugs Tongxinluo Capsule, Shensongyangxin Capsule and Qiliqiangxin Capsule for the treatment of cardiovascular and cerebrovascular diseases, forming a series of drugs for the treatment of cardiovascular and cerebrovascular diseases under the guidance of collateral diseases theory.
He presided over 8 national projects such as the Tenth Five-Year Plan, 863 projects of the Ministry of Science and Technology, major projects of the State Planning Commission, and projects funded by the National New Drug Fund, and more than 20 provincial scientific research projects. Tongxinluo capsule, which he studied, won the second prize of national scientific and technological progress award, the L special prize of governor and 8 provincial scientific and technological progress awards. Zeng edited Collateral Disease Theory of Traditional Chinese Medicine and Cardiovascular and Cerebrovascular Diseases.